Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination

Completed

Conditions studied: Papillomavirus Infections, Health Behavior, Attitude of Health Personnel, Human Papilloma Virus, Male

In brief

This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection. The research is focused on these questions: Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?

Key facts

Study ID
NCT02897232
Run by
Louisiana State University Health Sciences Center Shreveport
People needed
386
Starts
2016-07-01
Expected to finish
2020-04-01
Last updated by the study team
2021-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.